Helus Pharma

Toronto, Canada

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Jun 2026

Post-IPO Equity

Top Investors

RA Capital ManagementJanus Henderson InvestorsAdage Capital ManagementPoint72OrbiMed

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Helus Pharma's investors?

Helus Pharma's investors include RA Capital Management, Janus Henderson Investors, Adage Capital Management, Point72, OrbiMed.

Where is Helus Pharma headquartered?

Helus Pharma is headquartered in Toronto, Canada.

What does Helus Pharma do?

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

What stage is Helus Pharma at?

Helus Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 24, 2026.

MLA

"Helus Pharma — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/helus-pharma. Accessed June 30, 2026.

APA

VCBacked. (2026). Helus Pharma — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/helus-pharma

Wikipedia (cite web)

{{cite web |title=Helus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/helus-pharma |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 24, 2026.